Clinical Trial Update: TCF-001 TRACK (Target Rare Cancer Knowledge) Study [NA]

View source ↗

Summary

Clinical trial update for TCF-001 TRACK study (Target Rare Cancer Knowledge) is currently recruiting. The study targets cholangiocarcinoma and cancer of unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer of Unknown Primary Site
• Cholangiocarcinoma

Drugs mentioned

• TCF-001

Snippet

Sponsor: TargetCancer Foundation | Conditions: Rare Cancers, Cholangiocarcinoma | NA | Status: RECRUITING